Clinical Data Presented at ACC 2025 Shows Sensydia CPS™ Provides Accurate Assessment of Mean Pulmonary Artery Pressure Non-Invasively
/-- Non-invasive platform offers potential to transform heart failure care --
-- CPS on display for physicians in Sensydia booth #8029 at the American College of Cardiology (ACC) Annual Scientific Session & Expo --
CHICAGO, March 30, 2025--(BUSINESS WIRE)--Sensydia, a clinical-stage non-invasive cardiac assessment company, announced today that University of Minnesota investigators presented positive clinical findings from a recent study evaluating the company’s AI-powered, non-invasive Cardiac Performance System (CPS™) in a poster presentation at the American College of Cardiology (ACC) 2025 Annual Scientific Session & Expo at the McCormick Place Convention Center in Chicago, IL.